These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30137467)

  • 1. Risk of Meningioma in European Patients Treated With Growth Hormone in Childhood: Results From the SAGhE Cohort.
    Swerdlow AJ; Cooke R; Beckers D; Butler G; Carel JC; Cianfarani S; Clayton P; Coste J; Deodati A; Ecosse E; Hokken-Koelega ACS; Khan AJ; Kiess W; Kuehni CE; Flück CE; Pfaffle R; Sävendahl L; Sommer G; Thomas M; Tidblad A; Tollerfield S; Zandwijken GRJ
    J Clin Endocrinol Metab; 2019 Mar; 104(3):658-664. PubMed ID: 30137467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of growth hormone therapy on the occurrence of a second neoplasm in survivors of childhood cancer.
    Thomas-Teinturier C; Oliver-Petit I; Pacquement H; Fresneau B; Allodji RS; Veres C; Bolle S; Berchery D; Demoor-Goldschmidt C; Haddy N; Diallo I; de Vathaire F
    Eur J Endocrinol; 2020 Oct; 183(4):471-480. PubMed ID: 32738133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study.
    Swerdlow AJ; Cooke R; Beckers D; Borgström B; Butler G; Carel JC; Cianfarani S; Clayton P; Coste J; Deodati A; Ecosse E; Gausche R; Giacomozzi C; Hokken-Koelega ACS; Khan AJ; Kiess W; Kuehni CE; Mullis PE; Pfaffle R; Sävendahl L; Sommer G; Thomas M; Tidblad A; Tollerfield S; Van Eycken L; Zandwijken GRJ
    J Clin Endocrinol Metab; 2017 May; 102(5):1661-1672. PubMed ID: 28187225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the childhood cancer survivor study.
    Patterson BC; Chen Y; Sklar CA; Neglia J; Yasui Y; Mertens A; Armstrong GT; Meadows A; Stovall M; Robison LL; Meacham LR
    J Clin Endocrinol Metab; 2014 Jun; 99(6):2030-7. PubMed ID: 24606096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study.
    Sävendahl L; Maes M; Albertsson-Wikland K; Borgström B; Carel JC; Henrard S; Speybroeck N; Thomas M; Zandwijken G; Hokken-Koelega A
    J Clin Endocrinol Metab; 2012 Feb; 97(2):E213-7. PubMed ID: 22238393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Description of the SAGhE Cohort: A Large European Study of Mortality and Cancer Incidence Risks after Childhood Treatment with Recombinant Growth Hormone.
    Swerdlow AJ; Cooke R; Albertsson-Wikland K; Borgström B; Butler G; Cianfarani S; Clayton P; Coste J; Deodati A; Ecosse E; Gausche R; Giacomozzi C; Kiess W; Hokken-Koelega AC; Kuehni CE; Landier F; Maes M; Mullis PE; Pfaffle R; Sävendahl L; Sommer G; Thomas M; Tollerfield S; Zandwijken GR; Carel JC
    Horm Res Paediatr; 2015; 84(3):172-83. PubMed ID: 26227295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High incidence of meningioma in cranial irradiated survivors of childhood acute lymphoblastic leukemia.
    Goshen Y; Stark B; Kornreich L; Michowiz S; Feinmesser M; Yaniv I
    Pediatr Blood Cancer; 2007 Sep; 49(3):294-7. PubMed ID: 17243137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of benign meningioma after childhood cancer in the DCOG-LATER cohort: contributions of radiation dose, exposed cranial volume, and age.
    Kok JL; Teepen JC; van Leeuwen FE; Tissing WJE; Neggers SJCMM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; van den Heuvel-Eibrink MM; van Dulmen-den Broeder E; van der Heiden-van der Loo M; Aleman BMP; Daniels LA; Haasbeek CJA; Hoeben B; Janssens GO; Maduro JH; Oldenburger F; van Rij C; Tersteeg RJHA; Hauptmann M; ; Kremer LCM; Ronckers CM
    Neuro Oncol; 2019 Feb; 21(3):392-403. PubMed ID: 30099534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morbidity and Mortality Associated With Meningioma After Cranial Radiotherapy: A Report From the Childhood Cancer Survivor Study.
    Bowers DC; Moskowitz CS; Chou JF; Mazewski CM; Neglia JP; Armstrong GT; Leisenring WM; Robison LL; Oeffinger KC
    J Clin Oncol; 2017 May; 35(14):1570-1576. PubMed ID: 28339329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meningiomas after cranial radiotherapy for childhood cancer: a single institution experience.
    Felicetti F; Fortunati N; Garbossa D; Biasin E; Rudà R; Daniele D; Arvat E; Corrias A; Fagioli F; Brignardello E
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1277-82. PubMed ID: 25609074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: preliminary report of the French SAGhE study.
    Carel JC; Ecosse E; Landier F; Meguellati-Hakkas D; Kaguelidou F; Rey G; Coste J
    J Clin Endocrinol Metab; 2012 Feb; 97(2):416-25. PubMed ID: 22238382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety Outcomes During Pediatric GH Therapy: Final Results From the Prospective GeNeSIS Observational Program.
    Child CJ; Zimmermann AG; Chrousos GP; Cummings E; Deal CL; Hasegawa T; Jia N; Lawrence S; Linglart A; Loche S; Maghnie M; Pérez Sánchez J; Polak M; Predieri B; Richter-Unruh A; Rosenfeld RG; Yeste D; Yorifuji T; Blum WF
    J Clin Endocrinol Metab; 2019 Feb; 104(2):379-389. PubMed ID: 30219920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary intracranial meningiomas after high-dose cranial irradiation: report of five cases and review of the literature.
    Strojan P; Popović M; Jereb B
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):65-73. PubMed ID: 10924973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pooled Analysis of Meningioma Risk Following Treatment for Childhood Cancer.
    Withrow DR; Anderson H; Armstrong GT; Hawkins M; Journy N; Neglia JP; de Vathaire F; Tucker MA; Inskip PD; Brenner AV; Stovall MA; Diallo I; Berrington de Gonzalez A; Veiga LHS
    JAMA Oncol; 2022 Dec; 8(12):1756-1764. PubMed ID: 36201196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Safety of Growth Hormone Treatment in Childhood: Two Large Observational Studies: NordiNet IOS and ANSWER.
    Sävendahl L; Polak M; Backeljauw P; Blair JC; Miller BS; Rohrer TR; Hokken-Koelega A; Pietropoli A; Kelepouris N; Ross J
    J Clin Endocrinol Metab; 2021 May; 106(6):1728-1741. PubMed ID: 33571362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term mortality after childhood growth hormone treatment: the SAGhE cohort study.
    Sävendahl L; Cooke R; Tidblad A; Beckers D; Butler G; Cianfarani S; Clayton P; Coste J; Hokken-Koelega ACS; Kiess W; Kuehni CE; Albertsson-Wikland K; Deodati A; Ecosse E; Gausche R; Giacomozzi C; Konrad D; Landier F; Pfaeffle R; Sommer G; Thomas M; Tollerfield S; Zandwijken GRJ; Carel JC; Swerdlow AJ
    Lancet Diabetes Endocrinol; 2020 Aug; 8(8):683-692. PubMed ID: 32707116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy-related Secondary Malignancy After Treatment of Childhood Malignancy: Cases from a Single Center.
    Ueda T; Migita M; Itabashi T; Tanabe Y; Uchimura R; Gocho Y; Yamanishi M; Kobayashi F; Yoshino M; Fujita A; Yamanishi S; Kaizu K; Hayakawa J; Asano T; Maeda M; Itoh Y
    J Nippon Med Sch; 2019 Sep; 86(4):207-214. PubMed ID: 31061250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of subsequent gliomas and meningiomas among 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study.
    Heymer EJ; Hawkins MM; Winter DL; Teepen JC; Sunguc C; Ronckers CM; Allodji RS; Alessi D; Sugden E; Belle FN; Bagnasco F; Byrne J; Bárdi E; Garwicz S; Grabow D; Jankovic M; Kaatsch P; Kaiser M; Michel G; Schindera C; Haddy N; Journy N; Česen Mazić M; Skinner R; Kok JL; Gunnes MW; Wiebe T; Sacerdote C; Maule MM; Terenziani M; Jakab Z; Winther JF; Lähteenmäki PM; Zadravec Zaletel L; Haupt R; Kuehni CE; Kremer LC; de Vathaire F; Hjorth L; Reulen RC
    Br J Cancer; 2024 Apr; 130(6):976-986. PubMed ID: 38243010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood ALL and second neoplasms.
    Maniar TN; Braunstein I; Keefe S; Hussen S; Abrams T; De Michele A; El-Deiry WS
    Cancer Biol Ther; 2007 Oct; 6(10):1525-31. PubMed ID: 17952026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second brain tumors following central nervous system radiotherapy in childhood.
    Chojnacka M; Pędziwiatr K; Skowrońska-Gardas A; Perek-Polnik M; Perek D; Olasek P
    Br J Radiol; 2014 Sep; 87(1041):20140211. PubMed ID: 24968876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.